Researchers at Carnegie Mellon University (CMU) in Pittsburgh have solved a critical problem in 3D bioprinting of tissue scaffolding. The technique is an advanced version of Freeform Reversible Embedding of Suspended Hydrogels (FRESH) that enables 3D printing with collagen to create biological components of unprecedented complexity and detail. A paper detailing use of the technique to create components of the human heart appeared in Science.